- Investing Ideas
- South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
ALTEOGEN
Market Cap: ₩19.2t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩357,500.00
7D
-3.2%
1Y
-8.0%
Celltrion
Market Cap: ₩42.8t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩204,500.00
7D
-2.2%
1Y
34.1%
Samsung BiologicsLtd
Market Cap: ₩72.3t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,516,000.00
7D
-6.2%
1Y
-5.7%